Literature DB >> 28711733

Expression and purification of TAT-NDRG2 recombinant protein and evaluation of its anti-proliferative effect on LNCaP cell line.

Fahimeh Farokhinejad1, Abbas Behzad Behbahani2, Gholam Reza Rafiei Dehbidi3, Mohammad Ali Takhshid4.   

Abstract

N-myc downstream regulated gene2 (NDRG2) belongs to tumor suppressor protein family of NDRG. Anti-proliferative and anti-metastasis of NDRG2 overexpression has been demonstrated in a number of tumors. The aim of this study was to fuse the gene of Trans Activator of Transcription (TAT) protein transduction domain with NDRG2 gene and express and purify TAT-NDRG2 fusion protein in order to investigate the effects of TAT-NDRG2 protein on proliferation and apoptosis of LNCaP prostate carcinoma cell line. pET28a-TAT-NDRG2 and pET28a-NDRG2 plasmids were constructed and transformed into E. coli-BL21(DE3). TAT-NDRG2 and NDRG2 proteins were expressed in the bacteria, purified using affinity chromatography and verified using western blotting. The effects of TAT-NDRG2 and NDRG2 protein treatment on LNCaP cells proliferation and apoptosis were evaluated using MTT assay and AnnexinV, 7-AAD flow cytometry assay, respectively. Western blot analysis confirmed the expression and purification of TAT-NDRG2 and NDRG2 proteins. Treatment of LNCaP cells with TAT-NDRG2 protein increased cell death and induced apoptosis significantly (P < 0.05) compared to control and NDRG2 protein-treated cells. These results suggest that TAT-NDRG2 protein can be considered as a therapeutic modality for the treatment of tumors.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; NDRG2; Prostate cancer; TAT peptide

Mesh:

Substances:

Year:  2017        PMID: 28711733     DOI: 10.1016/j.pep.2017.07.004

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  2 in total

1.  Specific Targeting of Recombinant Human Pancreatic Ribonuclease 1 using Gonadotropin-Releasing Hormone Targeting Peptide toward Gonadotropin-Releasing Hormone Receptor-Positive Cancer Cells.

Authors:  Amir Maleksabet; Hossein Zarei Jaliani; Amir Asgari; Amin Ramezani; Nasrollah Erfani
Journal:  Iran J Med Sci       Date:  2021-07

2.  NDRG2 Regulates the Expression of Genes Involved in Epithelial Mesenchymal Transition of Prostate Cancer Cells.

Authors:  Mohammad Moradi Monfared; Marziyeh Alizadeh Zarei; Gholamreza Rafiei Dehbidi; Abbas Behzad Behbahani; Rita Arabsolghar; Mohammad Ali Takhshid
Journal:  Iran J Med Sci       Date:  2019-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.